HU Senan, AI Honghong, YE Xuelian, CHENG Jiangyan. Relationship between complement 3,interleukin 35 and the severity and prognosis of sepsis[J]. Laboratory Medicine, 2021, 36(1): 25-29.
COOPERSMITH C M,WUNSCH H,FINK M P,et al.A comparison of critical care research funding and the financial burden of critical illness in the United States[J]. Crit Care Med,2012,40(4):1072-1079.
[2]
王勇强,王兵. 脓毒症的诊治[J]. 中华急诊医学杂志,2013,22(2):222-224.
[3]
EGWUAGU C E,YU C R,SUN L,et al. Interleukin 35:critical regulator of immunity and lymphocyte-mediated diseases[J]. Cytokine Growth Factor Rev,2015,26(5):587-593.
[4]
CHARCHAFLIEH J,RUSHBROOK J,WORAH S,et al. Activated complement factors as disease markers for sepsis[J]. Dis Markers,2015,2015:382463.
[5]
LUPU F,KESHARI R S,LAMBRIS J D,et al. Crosstalk between the coagulation and complement systems in sepsis[J]. Thromb Res,2014,133(Suppl 1):S28-S31.
WIRTZ S,BILLMEIER U,MCHEDLIDZE T,et al. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis[J]. Gastroenterology,2011,141(5):1875-1886.
[10]
BAI J,QIU S L,ZHONG X N,et al.Erythromycin enhances CD4+Foxp3+regulatory T-cell responses in a rat model of smoke-induced lung inflammation[J]. Mediators lnflamm,2012,2012:410232.
[11]
ZIMMER J,HOBKIRK J,MOHAMED F,et al.On the functional overlap between complement and anti-microbial peptides[J]. Front Immunol,2015,5:689.
LIAO Juan, LIN Lixing, LI Yangyu, QIN Xuejun, ZHOU Zixin, CHEN Rongyan, SONG Yanfang, LIN Qing.
sCD14-ST in the early diagnosis of sepsis
[J]. Laboratory Medicine, 2016, 31(7): 562-566.